A Cohort Study on Sleep Disorders During Pregnancy

Status Recruiting

Clinical Trial Summary

The goal of this observational study is to: 1) determine the prevalence of sleep disorders in pregnancy and the early postpartum; 2) identify factors associated with sleep disturbance during pregnancy and the early postpartum; 3) describe the progression of sleep quality and quantity as gestational age; 4) determine if sleep is associated with adverse perinatal outcomes. Participants were asked to wear a forehead sleep recorder for 4 consecutive days and to complete a sleep questionnaire at ten timepoints: at 3 months, 4 months, 5 months, 6 months, 7 months, 8 months, and 9 months pregnant and at 1 month, 2 months and 3 months postpartum.

Clinical Trial Description

There is a high incidence of sleep disturbances globally, especially among pregnant women. Long-term sleep disorders seriously affect the quality life of individuals, and it becomes undoubtedly an important public health problem. Studies have shown that sleep disorders during pregnancy can have short-term and long-term adverse effects on both mothers and their babies. In addition, sleep during pregnancy exhibits different characteristics at different stages. Most of the existing studies are based on the overall development trend to study sleep characteristics, ignoring potential individual differences. Based on the concept of precision medicine, this study intends to establish a cohort focusing on the sleep health of pregnant women, and carry out continuous home sleep monitoring of pregnant women from both subjective and objective perspectives. The aim of this study is, firstly, to explore the longitudinal change characteristics, potential classification and influencing factors of sleep during pregnancy; secondly, to analyze the differences in maternal and infant adverse outcomes among pregnant women with different sleep development trajectories. The final goal is to reveal the exposure window of maternal and infant adverse outcomes caused by sleep, thus improving the accuracy of outcome prediction, and promoting the development of accurate and personalized sleep management programs. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05765149
Study type	Observational
Source	Women's Hospital School Of Medicine Zhejiang University
Contact	Xiaoyan Yu, Master
Phone	+86 13575737900
Email	yuxy@zju.edu.cn
Status	Recruiting
Phase
Start date	February 17, 2023
Completion date	February 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05820919` - Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase	N/A
Recruiting	`NCT04786314` - The Effect of Hot and Cold Water Application on Pregnant Women With Restless Leg Syndrome	N/A
Recruiting	`NCT05775731` - Markers of Inflammation and of the Pro-thrombotic State in Hospital Shift and Day Workers
Recruiting	`NCT03326765` - Characterizing Sleep Disorders in Children and Adults With Tuberous Sclerosis Complex (TSC)	N/A
Completed	`NCT03673397` - The Acute Effect of Aerobic Exercise on Sleep in Patients With Depression	N/A
Completed	`NCT03903263` - Sleep Disturbances in Dermatology Patients
Not yet recruiting	`NCT05950932` - Effects of Melissa Extract on Sleep Characteristics	Phase 4
Not yet recruiting	`NCT06012513` - Sleep Disorders and Quality of Life in Patients With Multiple Sclerosis
Completed	`NCT01463839` - Sleep Disorder and Oral Habits in Children	N/A
Completed	`NCT00940589` - Efficacy of Circadin® 2 mg in Patients With Mild to Moderate Alzheimer Disease Treated With AChE Inhibitor	Phase 2
Recruiting	`NCT06093633` - A Prospective Study to Evaluate the WP in Comparison to PSG in Patients Suspected of Sleep Disorders
Completed	`NCT06108115` - Smartphone-Based Intervention for Sleep Disturbance in Individuals Recovering From Alcohol Use Disorder	N/A
Completed	`NCT05511818` - Radicle Rest: A Study of Cannabinoids on Sleep and Health Outcomes	N/A
Active, not recruiting	`NCT04291014` - Light Therapy for PD - Dose Selection	N/A
Completed	`NCT04560595` - Remote Guided Caffeine Reduction	N/A
Completed	`NCT06008470` - Investigation of Respiratory Muscle Strength, Exercise Capacity, Physical Activity and Sleep Quality Level in Individuals With Covid-19 Infection
Recruiting	`NCT06129942` - Light Therapy in Parkinson's Disease	N/A
Recruiting	`NCT04318067` - Melatonin in ADHD and Sleep Problems	Phase 4
Completed	`NCT03857802` - Efficiency of a Nursing Intervention in Sleep Hygiene	N/A
Completed	`NCT03532269` - Validation of the Sleep Assessment Algorithm in the Medical Application Nightly	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.